Cargando…
Long-term multiple metabolic abnormalities among healthy and high-risk people following nonsevere COVID-19
Few studies have identified the metabolic consequences of the post-acute phase of nonsevere COVID-19. This prospective study examined metabolic outcomes and associated factors in nonsevere, RT-PCR-confirmed COVID-19. The participants’ metabolic parameters, the prevalence of long-term multiple metabo...
Autores principales: | Washirasaksiri, Chaiwat, Sayabovorn, Naruemit, Ariyakunaphan, Pinyapat, Kositamongkol, Chayanis, Chaisathaphol, Thanet, Sitasuwan, Tullaya, Tinmanee, Rungsima, Auesomwang, Chonticha, Nimitpunya, Pongpol, Woradetsittichai, Diana, Chayakulkeeree, Methee, Phoompoung, Pakpoom, Mayurasakorn, Korapat, Sookrung, Nitat, Tungtrongchitr, Anchalee, Wanitphakdeedecha, Rungsima, Muangman, Saipin, Senawong, Sansnee, Tangjittipokin, Watip, Sanpawitayakul, Gornmigar, Nopmaneejumruslers, Cherdchai, Vamvanij, Visit, Phisalprapa, Pochamana, Srivanichakorn, Weerachai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471587/ https://www.ncbi.nlm.nih.gov/pubmed/37653091 http://dx.doi.org/10.1038/s41598-023-41523-5 |
Ejemplares similares
-
Dynamics of Antibody Responses after Asymptomatic and Mild to Moderate SARS-CoV-2 Infections: Real-World Data in a Resource-Limited Country
por: Sayabovorn, Naruemit, et al.
Publicado: (2023) -
Early diagnosis by antigen test kit and early treatment by antiviral therapy: An ambulatory management strategy during COVID-19 crisis in Thailand
por: Sayabovorn, Naruemit, et al.
Publicado: (2022) -
Early antiviral and supervisory dexamethasone treatment improve clinical outcomes of nonsevere COVID-19 patients
por: Sitasuwan, Tullaya, et al.
Publicado: (2022) -
1345. Clinical Characteristics and Outcomes of Mild to Moderate COVID-19 Patients with Abnormal Chest Radiologic Findings Treated in the Hospitels in Thailand
por: Sayabovorn, Naruemit, et al.
Publicado: (2023) -
SARS-CoV-2 Antibody Response against Mild-to-Moderate Breakthrough COVID-19 in Home Isolation Setting in Thailand
por: Mongkolsucharitkul, Pichanun, et al.
Publicado: (2022)